Sumitovant Biopharma aims to make a difference in people’s lives by rapidly developing innovative medicines, using a technology-enabled approach to drug discovery, development and commercialization.
In 2021, GSK invested £5.3 billion in research and development (R&D), further growing a budget that has built a pipeline of 43 medicines and 21 vaccines, almost half of which address infectious ...
A business.com editor verified this analysis to ensure it meets our standards for accuracy, expertise and integrity. Business.com earns commissions from some listed providers. Editorial Guidelines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results